Christopher Weil

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Weil is an Assistant Professor at The University of Texas MD Anderson Cancer Center in the United States. He focuses his research on radiotherapy outcomes, immune checkpoint inhibitors, and the management of various cancers, particularly endometrial, breast, and meningioma cancers. His recent publications explore topics such as the impact of treatment techniques on survival rates and patterns of care in radiation therapy.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Gita Suneja

University of Utah

UNITED STATES

View details

Ying J. Hitchcock

UNITED STATES

View details

Randa Tao

University of Utah School of Medicine

UNITED STATES

View details

Dr. Charles R Rogers

Associate Professor; Endowed Chair

Medical College of Wisconsin

UNITED STATES

View details

Sarah T. Menacho

University of Utah

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Weil

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas

Combined immune checkpoint inhibitors and ablative radiotherapy in metastatic cancers: a meta-analysis of prospective clinical trials

Patterns of Care in Adjuvant Radiation Therapy for Stage II Endometrioid Endometrial Adenocarcinoma: A National Cancer Database Analysis

Patterns of failure after radiosurgery for WHO grade 1 or imaging defined meningiomas: Long-term outcomes and implications for management

Ultra‐low dose radiation therapy for primary cutaneous indolent B‐cell lymphomas

Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer

Gross Tumor and Intracranial Control Benefits with Fractionated Radiotherapy Compared with Stereotactic Radiosurgery for Patients with WHO Grade 2 Meningioma

International Federation of Gynecology and Obstetrics Endometrial 2023 Is Better For Radiation Oncology Patients

The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b–N3c Disease Who Receive Adjuvant Radiotherapy

Case report: Efficacy of lutetium-177 oxodotreotide for neuroendocrine tumor with central nervous system metastases

Importance of radiographic tumor regression during radiotherapy in squamous cell versus adenocarcinoma of the uterine cervix as assessed by MRI and cone beam CT

Trends in use of radiation therapy, chemotherapy, and combination chemoradiotherapy in advanced uterine cancer before, during, and after GOG 258

Benefits of Adopting Hypofractionated Radiotherapy as a Standard of Care in Low-and Middle-Income Countries.

Benefits of Adopting Hypofractionated Radiotherapy as a Standard of Care in Low-and Middle-Income Countries

Survival outcomes for patients with T3N0M0 squamous cell carcinoma of the glottis treated with definitive radiation alone versus chemoradiation.

Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy.

Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy

Patterns of care and outcomes of early stage I-II Hodgkin lymphoma treated with or without radiation therapy.

Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy.

Collaborators (5)

Gita Suneja

Ying J. Hitchcock

Randa Tao

Dr. Charles R Rogers

Sarah T. Menacho

Make your next move.